Antimicrobial Agents and Chemotherapy

Diseases, Conditions, Syndromes

Experimental antibiotic treats deadly MRSA infection

A new experimental antibiotic developed by a team of scientists at Rutgers University successfully treats the deadly MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has become ineffective ...

Diseases, Conditions, Syndromes

Modeling the correct doses for disease-fighting drugs

In treating diseases with drugs, dosing is critical; too little is ineffective, while too much can be lethal. Colorado State University's Brad Reisfeld takes a mathematical approach to achieving optimal dosing for various ...

Diseases, Conditions, Syndromes

New compound shows promise against malaria

Malaria parasites cause hundreds of millions of infections, and kills hundreds of thousands of people annually, mostly in Africa. And in recent years the most dangerous malaria parasite, Plasmodium falciparum, has become ...

Diseases, Conditions, Syndromes

US to establish lab network for combating 'superbugs'

US authorities said Tuesday they are establishing a network of labs that can respond quickly to antibiotic-resistant "superbugs," following America's first human case of a dangerous strain of E. coli.

Diseases, Conditions, Syndromes

New hybrid drug plugs the hole in malaria drug resistance

A combination of artemisinin and another drug (artemisinin combination therapy, ACT) is currently the best malaria treatment recommended by the World Health Organization. In early 2015, artemisinin-resistant malaria was confirmed ...

Diseases, Conditions, Syndromes

Antibiotic resistance—it's a social thing

Trace concentrations of antibiotic, such as those found in sewage outfalls, are enough to enable bacteria to keep antibiotic resistance, new research from the University of York has found. The concentrations are much lower ...

page 8 from 14